西点药业：10月27日召开董事会会议

Group 1 - The core point of the article is that Xidun Pharmaceutical announced the convening of its 13th meeting of the 8th Board of Directors on October 27, 2025, to review the proposal for the Q3 2025 report [1] - For the first half of 2025, Xidun Pharmaceutical's revenue composition shows that pharmaceuticals accounted for 99.39% of total revenue, while other businesses contributed 0.61% [1] - As of the time of reporting, Xidun Pharmaceutical has a market capitalization of 2.4 billion yuan [2]